Cited by 56Sirtuins and Resveratrol in MedicineAdipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases

SIRT1 limits adipocyte hyperplasia through c-Myc inhibition

Open access
Abdesselem, Houari, Madani, Aisha, Hani, Ahmad, Al-Noubi, Muna, Goswami, Neha, Ben Hamidane, Hisham, Billing, Anja M., Pasquier, Jennifer +9 more·2016·Journal of Biological Chemistry

Abstract

The expansion of fat mass in the obese state is due to increased adipocyte hypertrophy and hyperplasia. The molecular mechanism that drives adipocyte hyperplasia remains unknown. The NAD(+)-dependent protein deacetylase sirtuin 1 (SIRT1), a key regulator of mammalian metabolism, maintains proper metabolic functions in many tissues, counteracting obesity. Here we report that differentiated adipocytes are hyperplastic when SIRT1 is knocked down stably in mouse 3T3-L1 preadipocytes. This phenotype is associated with dysregulated adipocyte metabolism and enhanced inflammation. We also demonstrate that SIRT1 is a key regulator of proliferation in preadipocytes. Quantitative proteomics reveal that the c-Myc pathway is altered to drive enhanced proliferation in SIRT1-silenced 3T3-L1 cells. Moreover, c-Myc is hyperacetylated, levels of p27 are reduced, and cyclin-dependent kinase 2 (CDK2) is activated upon SIRT1 reduction. Remarkably, differentiating SIRT1-silenced preadipocytes exhibit enhanced mitotic clonal expansion accompanied by reduced levels of p27 as well as elevated levels of CCAAT/enhancer-binding protein β (C/EBPβ) and c-Myc, which is also hyperacetylated. c-Myc activation and enhanced proliferation phenotype are also found to be SIRT1-dependent in proliferating mouse embryonic fibroblasts and differentiating human SW872 preadipocytes. Reducing both SIRT1 and c-Myc expression in 3T3-L1 cells simultaneously does not induce the adipocyte hyperplasia phenotype, confirming that SIRT1 controls adipocyte hyperplasia through c-Myc regulation. A better understanding of the molecular mechanisms of adipocyte hyperplasia will open new avenues toward understanding obesity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m115.675645

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Abdesselem, H., Madani, A., Hani, A., Al-Noubi, M., Goswami, N., Ben Hamidane, H., Billing, A. M., Pasquier, J., Bonkowski, M. S., Halabi, N., Dalloul, R., Sheriff, M. Z., Mesaeli, N., ElRayess, M., Sinclair, D. A., Graumann, J., & Mazloum, N. A.
Affiliations
  • Weill Cornell Medical College in Qatar (QA)
  • Harvard University (US)
  • Anti-Doping Laboratory (QA)
Corresponding author
Mazloum, Nayef A.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2016-01
Volume
291
Issue
5
Pages
2119-2135
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2196929460
Cited by
56
References
43
Citations by year
2026: 2 · 2025: 8 · 2024: 7 · 2023: 8 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 4 · 2016: 7 · 2015: 1
FWCI
2.84
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • GlaxoSmithKline
  • Qatar Foundation
  • Weill Cornell Medicine - Qatar
  • National Institute on Aging (R37AG028730)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
SIRT1, adipocyte hyperplasia, c-Myc, adipocyte proliferation, preadipocyte differentiation, obesity, protein deacetylation, p27, CDK2, C/EBPβ, adipocyte metabolism, adipose tissue inflammation, mitotic clonal expansion
MeSH terms
Animals, Cell Differentiation, Fibroblasts, Gene Expression Regulation, Humans, Hyperplasia, Hypertrophy, Inflammation, Obesity, Proto-Oncogene Proteins c-myc, Adipocytes, Gene Silencing, CCAAT-Enhancer-Binding Protein-beta, Proteomics, 3T3-L1 Cells, Cell Proliferation, Mice, Sirtuin 1, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review